| Institution | Analyst name | Phone number |
|---|---|---|
| ABN Amro Oddo BHF | Martijn den Drijver | +31 (20) 62 80 042 |
| Alpha Value | Adrien Brasey | +33 (1) 7061 1050 |
| BNP Paribas Exane | Mourad Lahmidi | +33 (1) 4299 5063 |
| Degroof Petercam | Frank Claassen | +31 (20) 57 35 409 |
| ING Financial Markets | Stijn Demeester | +32 (2) 557 16 92 |
| KBC Securities | Wim Hoste | +32 (2) 429 37 13 |
| Kepler Cheuvreux | Alexander Craeymeersch | +32 (11) 49 14 64 |
| Van Lanschot Kempen | Chase Coughlan | +31 (6) 1606 5646 |
On 15 April 2025, the average target price for the Bekaert share, based on the recommendations of the 6 covering research analysts, amounts to €42,77.
The analysts’ target prices vary between €33,90 and €55.00.
3 analysts recommend to BUY the Bekaert share, 3 analysts report a HOLD/NEUTRAL and 1 analyst reports a REDUCE recommendation.
The last estimate was received on 14 April 2025.
The forecasts are prepared by the sell side analysts and provided to Bekaert Group. The consensus data is presented by Bekaert Group for information only. Bekaert Group does not endorse or express any view on any forecasts or information provided. Bekaert Group does not publish guidance or forecasts for these measures of financial performance.
Although Bekaert will endeavour to procure that the information is kept updated, Bekaert assumes no obligation to update or revise such information to reflect circumstances existing after the date hereof. It should be noted that forecasts are by definition forward looking and are therefore subject to risks and uncertainties that may materially affect eventual results. Bekaert Group does not accept any liability for reliance upon, or actions taken based on, any of the information set out in this consensus data.
In order for the consensus to accurately reflect the current views of the analyst community, we reserve the right to exclude any forecast which is not current. This is defined as those forecasts which do not reflect any commentary or guidance reported by management within 30 days of the most recent results announcement.
Bekaert disclaims any liability for statements made or published by third parties and does not undertake any obligation to correct inaccurate data, information, conclusions or opinions published by third parties in relation to this or any other information source provided by Bekaert.
